Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07559227 · ClinicalTrials.gov registry record · NA
Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
A NA study, sponsored by Ball State University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07559227 is a NA study that is actively recruiting participants, run by Ball State University. The registered enrollment target is 70 participants.
The verdict
NCT07559227, a NA study, is actively recruiting participants, sponsored by Ball State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The investigators seek to better understand how a single high-fat meal impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity" (obesity and largely normal cardiometabolic profile) and "metabolically healthy normal-weight individuals." Second, the investigators seek to understand how a prebiotic fiber (inulin) impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity."
Interventions
- DIETARY_SUPPLEMENT Maltodextrin (Placebo)
- OTHER High-fat meal
- DIETARY_SUPPLEMENT Inulin Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07559227
The ClinicalTrials.gov registry entry for NCT07559227 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ball State University, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Maltodextrin (Placebo) is the first listed.
NCT07559227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07559227 about?
NCT07559227 is a clinical study titled "Gut, Immune, and Vascular Health in Metabolically Healthy Obesity". The investigators seek to better understand how a single high-fat meal impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity" (obesity and largely normal cardiometabolic profile) and "metabolically healthy normal-weight individuals." Second, the investigators ...
What is the current status of trial NCT07559227?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-03-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07559227?
The interventions under investigation include: Maltodextrin (Placebo) (DIETARY_SUPPLEMENT), High-fat meal (OTHER), Inulin Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07559227?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.